Literature DB >> 7939786

Hepatobiliary disease in cystic fibrosis.

C Colombo1, P M Battezzati, M Podda.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7939786     DOI： 10.1055/s-2007-1007316

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  6 in total

1.  Retrospective review of cystic fibrosis presenting as infantile liver disease.

Authors:  R Shapira; N Hadzic; R Francavilla; G Koukulis; J F Price; G Mieli-Vergani
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

Review 2.  The gallbladder and biliary tract in cystic fibrosis.

Authors:  Michael P Curry; John E Hegarty
Journal:  Curr Gastroenterol Rep       Date:  2005-05

3.  Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.

Authors:  Sunil Sheth; Julie C Shea; Michele D Bishop; Sanjiv Chopra; Meredith M Regan; Emily Malmberg; Carolyn Walker; Ryan Ricci; Lap-Chee Tsui; Peter R Durie; Julian Zielenski; Steven D Freedman
Journal:  Hum Genet       Date:  2003-06-03       Impact factor: 4.132

4.  Cystic fibrosis-related liver disease: a single-center experience.

Authors:  Paula Catarino Costa; Celeste Canha Barreto; Luisa Pereira; Maria Luisa Lobo; Maria Adília Costa; Ana Isabel Gouveia Lopes
Journal:  Pediatr Rep       Date:  2011-10-17

Review 5.  Transport systems in cholangiocytes: their role in bile formation and cholestasis.

Authors:  M Strazzabosco
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug

6.  Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease?

Authors:  C Lemaitre; S Dominique; E Billoud; M Eliezer; H Montialoux; M Quillard; G Riachi; E Koning; H Morisse-Pradier; G Savoye; C Savoye-Collet; O Goria
Journal:  Can Respir J       Date:  2016-06-26       Impact factor: 2.409
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.